Opinion|Videos|October 3, 2024
Managed Care Challenges and Solutions for PDT Coverage, and Evaluating Patient Outcomes and Satisfaction
Author(s)Arwen Podesta, MD
Dr. Podesta discuss the managed care coverage challenges related to PDTs and explore strategies for improving patient access, while also addressing methods for evaluating patient outcomes and satisfaction with PDTs.
Advertisement
Episodes in this series
- Have you encountered managed care coverage challenges related to PDTs?
- How can managed care help ensure that appropriate patients have access to PDTs?
- With PDTs, how are patient outcomes and patient satisfaction evaluated?
Advertisement
Related to this article
In this discussion, Ohio State economist Eric Seiber, Ph.D., explains how inconsistent claims-data definitions can skew estimates of first-episode psychosis and why standardization matters for early treatment and sustainable payment models.
CMS’ mandatory GLOBE drug model ties some Medicare Part B rebates to global prices, but cuts projected savings sharply amid shifting Part D premiums.
Bill Kerr of Avalon Heath Solutions says incorporating Z codes into CPT codes for lab and genetic testing would add needed specificity, reduce waste and possibly head off fraud.
States have to turn that information into medical frailty determinations that are clinically credible, consistent, and workable across large Medicaid populations.
A meta-analysis found steatotic liver disease in 75% of patients with sleep-disordered breathing and that CPAP lowered liver enzymes but not liver fat.
Some predicted that drugmakers might boost launch prices to make up for Medicare drug negotiations shrinking profits. Harvard researchers find no evidence of that happening so far.
State PBM reform accelerates through 2026, with Theresa Carnegie of Mintz unpacking new laws, rebate pass-through, spread pricing bans, and compliance risks.
Only 19.1% of commercially insured patients with first-episode psychosis were adherent to antipsychotics in the year after starting treatment.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FAQ: State PBM reform in 2026—What's new since spring
2
CMS defined a path for medical frailty. Now comes the hard part.
3
When the referral isn't the finish line: Making SDOH programs actually close care gaps
4
IRA drug price negotiation has not increased launch prices, study finds
5